Eplerenone Tablet, Coated
Product Images NDC 69367-308

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 69367-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Eplerenone 01)

Chemical structure of eplerenone, depicting its steroid framework including multiple rings and attached functional groups consistent with the chemical identity of the active ingredient eplerenone.*

FDA Label Image

Figure 1 (Eplerenone 02)

A line graph showing cumulative incidence (%) over months since randomization for Eplerenone versus Placebo groups. The Eplerenone group shows a consistently lower cumulative incidence compared to Placebo. The graph includes a p-value of 0.008 and a relative risk (RR) of 0.85 with 95% confidence interval 0.75 to 0.96. Numbers at risk for each group are listed below the x-axis at various time points up to 27 months.*

FDA Label Image

Figure 2 (Eplerenone 03)

A forest plot chart titled 'Hazard Ratios of All-Cause Mortality by Subgroups' displaying hazard ratios with 95% confidence intervals for various patient subgroups. Subgroups include age, gender, race, diabetes status, hypertension history, Killip class, creatinine clearance, and baseline use of beta blockers, ACE inhibitors, digoxin, and diuretics. The x-axis ranges from 0.0 to 2.0, comparing eplerenone and placebo outcomes, with vertical markers indicating hazard ratios and confidence intervals for each subgroup.*

FDA Label Image

Figure 3 (Eplerenone 04)

A scatter plot graph depicting the reduction in systolic blood pressure (SBP) in mm Hg on the vertical axis versus Eplerenone dosage in mg/day on the horizontal axis. The graph compares data points from three study groups labeled as Study 1 QD, Study 2 QD, and Study 2 BID, showing variation in blood pressure reduction across different dosages ranging from approximately 0 to 200 mg/day.*

FDA Label Image

Figure 4 (Eplerenone 05)

A scatter plot showing the reduction in diastolic blood pressure (DBP) in mm Hg as a function of daily Eplerenone dosage in mg/day. The graph features data points from three studies labeled as Study 1 QD, Study 2 QD, and Study 2 BID, illustrating varying DBP reductions at different Eplerenone doses up to approximately 200 mg/day.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Eplerenone 25 mg coated tablets label from Westminster Pharmaceuticals, LLC. The label states the dosage strength as 25 mg and the package contains 90 tablets. It includes storage instructions, manufacturer details in Portugal, and a barcode. The product is prescription-only (Rx Only) with NDC 69367-307-09.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Label for Eplerenone Tablets 50 mg by Westminster Pharmaceuticals, LLC. The label states the product contains 90 coated tablets, each with 50 mg of eplerenone for oral use. Storage instructions and distributor and manufacturer details are provided, along with an NDC number and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.